foxo4-dri peptide senolytic study Buy (Proxofim) The disordered p53 transactivation domain

SKU: 53721249393

Pay in 4 interest-free payments of $6.91 Learn more

Live Spec

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology foxo4 dri experiment Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026) FOXO4 DRI 10mg Peptide Bluewell

Store: avramcheva.com · Domain: avramcheva.com